Please select your preferences to subscribe.

COVID-19 vaccines hold strong against Delta, protection waning in older adults

  • >> Reuters
    Published: 2021-09-11 09:33:26 BdST

Ananya Salam Samata, a fifth-year student at Dhaka Medical College, makes a victory sign after receiving a shot of Sinopharm’s coronavirus vaccine on Tuesday, May 25, 2021.

Three US studies suggest COVID-19 vaccines offer strong protection against hospitalisation and death, even in the face of the highly transmissible Delta variant, but vaccine protection appears to be waning among older populations, especially among those 75 and older.

US data on hospitalisation from nine states during the period when the Delta variant was dominant also suggests that the Moderna Inc vaccine was more effective at preventing hospitalisations among individuals of all ages than vaccines from BioNTech/Pfizer Inc or Johnson & Johnson.

In that study of more than 32,000 visits to urgent care centers, emergency rooms and hospitals, Moderna's vaccine was 95 percent effective at preventing hospitalisation compared with 80 percent for Pfizer and 60 percent for J&J.

Overall, the findings, released on Friday in the US Centers for Disease Control and Prevention's weekly report on death and disease show that vaccines continue to offer strong protection from COVID-19.